|
|
|
For Dr. Waters’ presentation to the support group which goes far deeper into the topic: https://madisonarealymesupportgroup.com/2015/04/18/dr-waters-presentation/
https://madisonarealymesupportgroup.com/2020/02/13/washington-doctors-successfully-treat-coronavirus/ using the anti-viral remdesivir.
https://www.foxnews.com/media/rand-paul-gives-first-interview-since-recovering-from-covid-19? Video Interview Here
In his first interview since recovering from COVID-19, Sen. Rand Paul, R-Ky., described what it was like to contract the new coronavirus.
“I had an extraordinarily mild case,” Paul, who is also a doctor, said on “Fox & Friends” on Monday. “I had no symptoms, never had a headache, never had a body ache, never had a fever, never had a cough.”
He added that he would not have gone to the hospital or the doctor’s office if he didn’t know it was going around and if he hadn’t been traveling so much.
“It’s a bizarre sort of situation that some people get very, very sick, even die from this and some people get no symptoms,” Paul said.
___________________
**Comment**
This is important because the media is pushing the idea that everyone is getting severely sick and dying from this. Please remember that the vast majority get a mild case or as in this situation, no symptoms at all, and go on with life.
Again, this immunity issue is completely avoided by mainstream media but is extremely important. By holing up and avoiding each other, we are not allowing nature to run its course. Of course those who are ill should take proper measures but the world – wide quarantining we are experiencing defies all that is known about viruses.
https://danielcameronmd.com/boy-with-severe-cardiac-lyme-disease/
Nawrocki and his colleague first discussed this case in the Air Medical Journal in 2018.
A 15-year-old boy experienced an episode of exertional syncope while at a trampoline park. Syncope is a temporary loss of consciousness.
He had a history of an attention-deficit/hyperactivity disorder.
His friends immediately called 911. They were not sure how long he was unconscious.
The boy was pale with a heart rate of 300 beats per minute, according to the medics. His EKG showed a wide complex tachyarrhythmia. That means that the heart is fast, and the QRS parts of his EKG were wide.
He was given a dose of amiodarone, but the ventricular tachycardia remained a problem. Amiodarone is a medicine used to treat and prevent irregular heartbeats.
At the hospital, he was dizzy and was short of breath. His heart rate remained between 290 and 300. His blood pressure dropped to 66/30 mm Hg.
He required synchronized cardioversion. Synchronized cardioversion is a procedure similar to electrical defibrillation. Synchronized cardioversion uses low energy synchronized with the heart.
His EKG changed to a third-degree heart block. That occurs when there is a complete block of impulses from the atrium to the ventricle. The atrium is the top of the heart, and the ventricle is the bottom. He had pacing pads placed.
He was flown to a cardiac intensive care unit (ICU) at a children’s tertiary care hospital via rotary-wing aircraft staffed with two flight nurses.
He continued to have a complete heart block with a fast rhythm.
Doctors suspected Lyme disease and prescribed intravenous ceftriaxone. The diagnosis of Lyme disease was confirmed by “anti-Lyme titers” and Western blot tests.
His low heart rate and low pressure continued. The doctors inserted a transvenous pacemaker to control the heart rate.
He had three additional episodes of ventricular tachycardia. He was cardioverted twice.
The authors note that conduction problems have been reported previously in untreated Lyme disease. The list of conduction abnormalities includes first and second-degree AV block, ST and T wave changes, prolonged QT, junctional tachycardia, and complete heart block.
What can we learn from these cases?
What questions do these cases raise?
In my practice, each individual requires a careful assessment. That is why I order a broad range of blood tests for other illnesses in addition to tick-borne infections. I also arrange consultations with specialists as needed.
Many patients are complex, as highlighted in this Inside Lyme Podcast series.
We need more doctors with skills recognizing Lyme carditis. We hope that professionals evaluating individuals with Lyme carditis can use this case to remind them to look for tick-borne illnesses and treat accordingly.
This Inside Lyme case series will be discussed on my Facebook and made available on podcast and YouTube. As always, it is your likes, comments, and shares that help spread the word about this series and our work. If you can, please leave a review on iTunes or wherever else you get your podcasts.
Sign up for our newsletter to keep up with our cases.
___________________
https://madisonarealymesupportgroup.com/2019/12/09/study-identifies-189-children-with-lyme-carditis/
https://madisonarealymesupportgroup.com/2019/06/04/how-vector-borne-diseases-impact-heart-health/
https://madisonarealymesupportgroup.com/2018/06/03/heart-problems-tick-borne-disease/
https://neurosciencenews.com/zinc-coronavirus-16121/
Summary: University of Melbourne researchers are conducting trials to see if intravenous administration of zinc chloride will help combat some of the effects of COVID-19. Previous studies have shown zinc is effective at slowing the rate of other respiratory infections, such as SARS.
Source: University of Melbourne
A world-first trial will see researchers from Austin Health and the University of Melbourne use intravenous zinc to fight the symptoms of coronavirus (COVID-19).
The trial will be led by Dr Joseph Ischia from Austin Health, along with Dr Oneel Patel from the Department of Surgery at the University of Melbourne, who has a long history of investigating the protective effects of intravenous zinc against organ damage induced by lack of oxygen.
Dr Ischia said COVID-19 is especially dangerous because it replicates inside a patient’s body which can lead to respiratory conditions like bronchitis and pneumonia.
“If COVID-19 enters a patient’s lungs then they often need to be placed on a ventilator to help their breathing and, in severe cases, COVID-19 can cause multiple organ failure and brain injury due to a lack of oxygen,” Dr Ischia said.
Dr Patel said studies have shown that zinc is very effective at slowing the rate that similar viruses such as SARS (Severe Acute Respiratory Syndrome) and common cold (a type of coronavirus) replicate in the body.
“Our published studies have also shown that high doses of zinc can protect vital organs such as the heart, kidneys and liver against the damage caused by a lack of oxygen,” Dr Patel said.
The clinical trial has been fast-tracked to test whether receiving a daily injection of zinc chloride will benefit patients with coronavirus.
“There is currently no specific treatment available for patients who have COVID-19 and are at high risk of respiratory failure, which means this study has the potential to have an enormous positive impact on their clinical outcomes,” Dr Ischia said.
“Importantly, we hope to show that we can save lives by limiting the impact of the symptoms. We are expecting to have preliminary results of the trial available after only seven days so we will know very quickly how effective this treatment is.”
The trial is the culmination of a rapid collaboration between surgeon scientists as well as intensive care, infectious diseases and respiratory medicine doctors at Austin Health, working with the Australian pharmaceutical firm, Phebra.
Phebra Chief Executive Officer Dr Mal Eutick said intravenous (IV) zinc injections, manufactured at Phebra’s multi-purpose sterile injectables plant in Sydney, would be used in the trial.
“Zinc has been proven to be effective in treating severe pneumonia and other viruses although not COVID-19 to date. This trial is an extraordinary opportunity to discover if IV zinc can help us respond to the current pandemic,” Dr Eutick said
“If successful this could save lives and with this trial we should know in a short time frame. In particular, it could be very important for those high risk elderly patients and also help reduce the level of general anxiety in the community.”
However, both Dr Ischia and Dr Eutick warned of the need to manage the risk of zinc overdose for patients.
“Zinc can be toxic and it will be carefully administered as part of the trial to ensure patients are safe,” Dr Ischia explained.
About this COVID-19 research article
Source:
University of Melbourne
Media Contacts:
Media team – University of Melbourne
Image Source:
The image is adapted from the University of Melbourne news release.
Feel Free To Share This Coronavirus News.
https://danielcameronmd.com/lyme-in-the-south-children-infected-camp/
Some doctors have questioned the existence of Lyme disease in the south, but in their “Morbidity and Mortality Weekly Report,” published January 2020, the Centers for Disease Control and Prevention (CDC) describe 4 cases of Lyme disease in young children who attended a wilderness day camp in North Carolina. [1]
The number of tick-borne diseases, including Lyme, has been steadily rising in the South as tick populations expand into new territories. One study reports, “The trends in these data paint a clear picture of southward expansion of Lyme disease.” As a result, communities once considered non-endemic for Lyme disease will be at risk, including those in the south, the study warns. [2]
The CDC recently reported several children infected with Lyme disease at a single camp, located in the south. The children, who were between the ages of 6 and 8, attended the wilderness day camp at least 1 day a week in the Fall and Spring. Three of the four children were homeschooled but attended the camp. Three children had ticks removed.
“Further investigation identified an earlier camp participant who had received a diagnosis of Lyme disease in 2017,” the authors explain.
READ MORE: Culture Evidence of Lyme disease in antibiotic-treated patients living in the Southeast
Using a “flagging and dragging” method across 0.27 acres of the camp, investigators collected 37 Ixodes Scapularis ticks, commonly called deer ticks.
Study Results
Out of 35 ticks tested, 6 were positive for B. burgdorferi sensu stricto, the causative agent of Lyme disease.
“Results indicated that nymphal ticks collected at the campsite had a B. burgdorferi infection prevalence of 17%,” the authors write.
None of the ticks tested positive for the pathogens responsible for Anaplasmosis or Babesia microti.
In 3 of the 4 children, blood tests confirmed a Lyme disease diagnosis. Two of the children had an erythema migrans (bull’s eye) rash. One was considered probable because the test was positive by ELISA and IgM Western blot but not IgG Western blot.
Symptoms and Treatment
The clinical presentations included brief, recurrent attacks of joint swelling, arthralgia, fever, headaches, loss of appetite, and fatigue. One had radiculoneuropathy and Bell’s palsy.
All were treated with doxycycline. The authors did not indicate how long they treated the young children or the outcome of treatment.
Authors Conclude
“Clinicians should be aware of the risk for transmission of Lyme disease in North Carolina and consider recommended diagnostic testing and treatment.”
Other studies have also identified ticks infected with the causative agent of Lyme disease in the south. One study reports, “The trends in these data paint a clear picture of southward expansion of Lyme disease.” As a result, communities once considered non-endemic for Lyme disease will be at risk, including the southeastern United States, the study warns. [2]
Northern immigrant ticks causing concern in the south
Kentucky is swarming with deer ticks: over 50% of counties infested
_________________
**Comment**
Lyme disease still is not recognized for the pandemic it truly is. This study demonstrates how authorities are still hanging on to ancient data that never was accurate to begin with.
Madison Area Lyme Support Group 